Cell senescence and cancer (original) (raw)

• Hayflick, L. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585–621 (1961).
  CAS PubMed Google Scholar
• Hayflick, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614–636 (1965).
  Article CAS PubMed Google Scholar
• Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363–9367 (1995).
  CAS PubMed PubMed Central Google Scholar
• Artandi, S. E. & DePinho, R. A. A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr. Opin. Genet. Dev. 10, 39–46 (2000).
  CAS PubMed Google Scholar
• Hara, E., Tsurui, H., Shinozaki, A., Nakada, S. & Oda, K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 179, 528–534 (1991).
  CAS PubMed Google Scholar
• Shay, J. W., Pereira-Smith, O. M. & Wright, W. E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196, 33–39 (1991).
  CAS PubMed Google Scholar
• Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458–460 (1990).
  CAS PubMed Google Scholar
• Bodnar, A. G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349–352 (1998).
  CAS PubMed Google Scholar
• Vaziri, H. & Benchimol, S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8, 279–282 (1998).References 8 and 9 show how telomerase expression immortalizes human cells.
  CAS PubMed Google Scholar
• Kiyono, T. et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84–88 (1998).Human epithelial cells seem to have, in addition to telomere shortening, a second checkpoint that determines replicative lifespan.
  CAS PubMed Google Scholar
• Di Leonardo, A., Linke, S. P., Clarkin, K. & Wahl, G. M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540–2551 (1994).
  CAS PubMed Google Scholar
• Robles, S. J. & Adami, G. R. Agents that cause DNA double strand breaks lead to p16INK4A enrichment and the premature senescence of normal fibroblasts. Oncogene 16, 1113–1123 (1998).
  CAS PubMed Google Scholar
• Chen, Q. & Ames, B. N. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc. Natl Acad. Sci. USA 91, 4130–4134 (1994).
  CAS PubMed PubMed Central Google Scholar
• Finkel, T. & Holbrook, N. J. Oxidants, oxidative stress and the biology of ageing. Nature 408, 239–247 (2000).
  CAS PubMed Google Scholar
• Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4A. Cell 88, 593–602 (1997).Oncogenic RAS expression in normal cells triggers premature senescence.
  Article CAS PubMed Google Scholar
• Sherr, C. J. & DePinho, R. A. Cellular senescence: mitotic clock or culture shock? Cell 102, 407–410 (2000).
  CAS PubMed Google Scholar
• Wright, W. E. & Shay, J. W. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nature Med. 6, 849–851 (2000).
  CAS PubMed Google Scholar
• Mathon, N. F., Malcolm, D. S., Harrisingh, M. C., Cheng, L. & Lloyd, A. C. Lack of replicative senescence in normal rodent glia. Science 291, 872–875 (2001).
  CAS PubMed Google Scholar
• Tang, D. G., Tokumoto, Y. M., Apperly, J. A., Lloyd, A. C. & Raff, M. C. Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science 291, 868–871 (2001).
  CAS PubMed Google Scholar
• Shay, J. W. & Wright, W. E. Aging: when do telomeres matter? Science 291, 839–840 (2001).
  CAS PubMed Google Scholar
• Ramirez, R. D. et al. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15, 398–403 (2001).References 18, 19 and 21 show that culture conditions, rather than an intrinsic clock, limit the proliferative lifespan of many cell types.
  CAS PubMed PubMed Central Google Scholar
• Kim, N. W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015 (1994).
  CAS PubMed Google Scholar
• Bryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A. & Reddel, R. R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Med. 3, 1271–1274 (1997).
  CAS PubMed Google Scholar
• Hastie, N. D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866–868 (1990).
  Article CAS PubMed Google Scholar
• Sommerfeld, H. J. et al. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res. 56, 218–222 (1996).
  CAS PubMed Google Scholar
• Hahn, W. C. et al. Inhibition of telomerase limits the growth of human cancer cells. Nature Med. 5, 1164–1170 (1999).Shows that cancer cells need to maintain telomerase activity.
  CAS PubMed Google Scholar
• Hahn, W. C. et al. Creation of human tumour cells with defined genetic elements. Nature 400, 464–468 (1999).How many genetic changes to transform a normal human cell?
  CAS PubMed Google Scholar
• Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25–34 (1997).Mouse cells lacking telomerase senesce at the same rate, are immortalized and are as transformable as wild-type cells.
  CAS PubMed Google Scholar
• Artandi, S. E. & DePinho, R. A. Mice without telomerase: what can they teach us about human cancer? Nature Med. 6, 852–855 (2000).
  CAS PubMed Google Scholar
• Lee, H. W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569–574 (1998).
  CAS PubMed Google Scholar
• Rudolph, K. L. et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701–712 (1999).Documents the unexpected finding that telomerase-deficient mice have an increased predisposition to cancer.
  CAS PubMed Google Scholar
• Hande, M. P., Samper, E., Lansdorp, P. & Blasco, M. A. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Biol. 144, 589–601 (1999).
  CAS PubMed PubMed Central Google Scholar
• Niida, H. et al. Severe growth defect in mouse cells lacking the telomerase RNA component. Nature Genet. 19, 203–206 (1998).
  CAS PubMed Google Scholar
• Counter, C. M. et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921–1929 (1992).
  CAS PubMed PubMed Central Google Scholar
• Hackett, J. A., Feldser, D. M. & Greider, C. W. Telomere dysfunction increases mutation rate and genomic instability. Cell 106, 275–286 (2001).
  CAS PubMed Google Scholar
• Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999).
  CAS PubMed Google Scholar
• Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641–645 (2000).
  CAS PubMed Google Scholar
• Serrano, M. et al. Role of the INK4A locus in tumor suppression and cell mortality. Cell 85, 27–37 (1996).
  CAS PubMed Google Scholar
• Greenberg, R. A. et al. Short dysfunctional telomeres impair tumorigenesis in the INK4A(δ2/3) cancer-prone mouse. Cell 97, 515–525 (1999).
  CAS PubMed Google Scholar
• Gonzalez-Suarez, E., Samper, E., Flores, J. M. & Blasco, M. A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nature Genet. 26, 114–117 (2000).
  CAS PubMed Google Scholar
• Rudolph, K. L., Millard, M., Bosenberg, M. W. & DePinho, R. A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nature Genet. 28, 155–159 (2001).References 39–41 show that replicative senescence can protect against tumorigenesis when the frequency of tumour initiation is increased.
  CAS PubMed Google Scholar
• Su, L. K. et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668–670 (1992).
  CAS PubMed Google Scholar
• Hart, R. W. & Setlow, R. B. Correlation between deoxyribonucleic acid excision-repair and life-span in a number of mammalian species. Proc. Natl Acad. Sci. USA 71, 2169–2173 (1974).
  CAS PubMed PubMed Central Google Scholar
• Kolquist, K. A. et al. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nature Genet. 19, 182–186 (1998).
  CAS PubMed Google Scholar
• Harle-Bachor, C. & Boukamp, P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl Acad. Sci. USA 93, 6476–6481 (1996).
  CAS PubMed PubMed Central Google Scholar
• Gonzalez-Suarez, E. et al. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 20, 2619–2630 (2001).Indicates that high levels of telomerase might have an additional proliferative effect.
  CAS PubMed PubMed Central Google Scholar
• Oh, H. et al. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc. Natl Acad. Sci. USA 98, 10308–10313 (2001).
  CAS PubMed PubMed Central Google Scholar
• Prowse, K. R. & Greider, C. W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl Acad. Sci. USA 92, 4818–4822 (1995).
  CAS PubMed PubMed Central Google Scholar
• Greenberg, R. A., Allsopp, R. C., Chin, L., Morin, G. B. & DePinho, R. A. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16, 1723–1730 (1998).
  CAS PubMed Google Scholar
• Blasco, M. A., Rizen, M., Greider, C. W. & Hanahan, D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nature Genet. 12, 200–204 (1996).
  CAS PubMed Google Scholar
• Chadeneau, C., Siegel, P., Harley, C. B., Muller, W. J. & Bacchetti, S. Telomerase activity in normal and malignant murine tissues. Oncogene 11, 893–898 (1995).
  CAS PubMed Google Scholar
• Vaziri, H. et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl Acad. Sci. USA 91, 9857–9860 (1994).
  CAS PubMed PubMed Central Google Scholar
• Vaziri, H. et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52, 661–667 (1993).
  CAS PubMed PubMed Central Google Scholar
• Zhang, A. et al. Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res. 60, 6230–6235 (2000).
  CAS PubMed Google Scholar
• Greenberg, R. A. et al. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18, 1219–1226 (1999).
  CAS PubMed Google Scholar
• Wu, K. J. et al. Direct activation of TERT transcription by c-MYC. Nature Genet. 21, 220–224 (1999).
  CAS PubMed Google Scholar
• Wang, J., Xie, L. Y., Allan, S., Beach, D. & Hannon, G. J. Myc activates telomerase. Genes Dev. 12, 1769–1774 (1998).
  CAS PubMed PubMed Central Google Scholar
• Oh, S. T., Kyo, S. & Laimins, L. A. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. J. Virol. 75, 5559–5566 (2001).
  CAS PubMed PubMed Central Google Scholar
• Klingelhutz, A. J., Foster, S. A. & McDougall, J. K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79–82 (1996).
  CAS PubMed Google Scholar
• Weinberg, R. A. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res. 49, 3713–3721 (1989).
  CAS PubMed Google Scholar
• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).
  CAS PubMed Google Scholar
• Lloyd, A. C. Ras versus cyclin-dependent kinase inhibitors. Curr. Opin. Genet. Dev. 8, 43–48 (1998).
  CAS PubMed Google Scholar
• Adams, J. M. & Cory, S. Transgenic models of tumor development. Science 254, 1161–1167 (1991).
  CAS PubMed Google Scholar
• Johnson, L. et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111–1116 (2001).
  CAS PubMed Google Scholar
• Lloyd, A. C. et al. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 11, 663–677 (1997).
  CAS PubMed Google Scholar
• Roper, E., Weinberg, W., Watt, F. M. & Land, H. p19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes. EMBO Rep. 2, 145–150 (2001).
  CAS PubMed PubMed Central Google Scholar
• Lin, A. W. & Lowe, S. W. Oncogenic ras activates the ARF–p53 pathway to suppress epithelial cell transformation. Proc. Natl Acad. Sci. USA 98, 5025–5030 (2001).
  CAS PubMed PubMed Central Google Scholar
• Lemoine, N. R. et al. Partial transformation of human thyroid epithelial cells by mutant H-ras oncogene. Oncogene 5, 1833–1837 (1990).
  CAS PubMed Google Scholar
• Foster, S. A., Wong, D. J., Barrett, M. T. & Galloway, D. A. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell Biol. 18, 1793–1801 (1998).
  CAS PubMed PubMed Central Google Scholar
• Romanov, S. R. et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 409, 633–637 (2001).
  CAS PubMed Google Scholar
• Hui, R. et al. INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis. Clin. Cancer Res. 6, 2777–2787 (2000).
  CAS PubMed Google Scholar
• Johnson, F. B., Sinclair, D. A. & Guarente, L. Molecular biology of aging. Cell 96, 291–302 (1999).
  CAS PubMed Google Scholar
• West, M. D., Pereira-Smith, O. M. & Smith, J. R. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp. Cell Res. 184, 138–147 (1989).
  CAS PubMed Google Scholar
• Ames, B. N., Shigenaga, M. K. & Hagen, T. M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl Acad. Sci. USA 90, 7915–7922 (1993).
  CAS PubMed PubMed Central Google Scholar
• DePinho, R. A. The age of cancer. Nature 408, 248–254 (2000).
  CAS PubMed Google Scholar
• Olumi, A. F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002–5011 (1999).
  CAS PubMed Google Scholar
• Krtolica, A., Parrinello, S., Lockett, S., Desprez, P. Y. & Campisi, J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl Acad. Sci. USA 98, 12072–12077 (2001).
  CAS PubMed PubMed Central Google Scholar
• Foster, B. A., Coffey, H. A., Morin, M. J. & Rastinejad, F. Pharmacological rescue of mutant p53 conformation and function. Science 286, 2507–2510 (1999).
  CAS PubMed Google Scholar
• Bullock, A. N. & Fersht, A. R. Rescuing the function of mutant p53. Nature Rev. Cancer 1, 68–76 (2001).
  CAS Google Scholar
• Collins, K. Mammalian telomeres and telomerase. Curr. Opin. Cell Biol. 12, 378–383 (2000).
  CAS PubMed Google Scholar
• Smogorzewska, A. et al. Control of human telomere length by TRF1 and TRF2. Mol. Cell Biol. 20, 1659–1668 (2000).
  CAS PubMed PubMed Central Google Scholar
• Griffith, J. D. et al. Mammalian telomeres end in a large duplex loop. Cell 97, 503–514 (1999).
  CAS PubMed Google Scholar
• Greider, C. W. Telomeres do D-loop–T-loop. Cell 97, 419–422 (1999).
  CAS PubMed Google Scholar
• Blackburn, E. H. Telomere states and cell fates. Nature 408, 53–56 (2000).
  CAS PubMed Google Scholar
• Hemann, M. T., Strong, M. A., Hao, L. Y. & Greider, C. W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67–77 (2001).
  CAS PubMed Google Scholar
• Karlseder, J., Broccoli, D., Dai, Y., Hardy, S. & de Lange, T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321–1325 (1999).
  CAS PubMed Google Scholar
• van Steensel, B., Smogorzewska, A. & de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell 92, 401–413 (1998).
  CAS PubMed Google Scholar
• Herrera, E. et al. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 18, 2950–2960 (1999).
  CAS PubMed PubMed Central Google Scholar
• Liu, Y. et al. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr. Biol. 10, 1459–1462 (2000).
  CAS PubMed Google Scholar
• Nikaido, R. et al. Presence of telomeric G-strand tails in the telomerase catalytic subunit Tert knockout mice. Genes Cells 4, 563–572 (1999).
  PubMed Google Scholar
• Herrera, E., Martinez, A. C. & Blasco, M. A. Impaired germinal center reaction in mice with short telomeres. EMBO J. 19, 472–481 (2000).
  CAS PubMed PubMed Central Google Scholar
• Chang, S., Khoo, C. & DePinho, R. A. Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse. Semin. Cancer Biol. 11, 227–239 (2001).
  CAS PubMed Google Scholar
• Blasco, M. A., Funk, W., Villeponteau, B. & Greider, C. W. Functional characterization and developmental regulation of mouse telomerase RNA. Science 269, 1267–1270 (1995).
  CAS PubMed Google Scholar
• Martin-Rivera, L., Herrera, E., Albar, J. P. & Blasco, M. A. Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc. Natl Acad. Sci. USA 95, 10471–10476 (1998).
  CAS PubMed PubMed Central Google Scholar
• Brien, T. P. et al. Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res. 57, 2760–2764 (1997).
  CAS PubMed Google Scholar
• Bodnar, A. G., Kim, N. W., Effros, R. B. & Chiu, C. P. P. Mechanism of telomerase induction during T cell activation. Exp. Cell Res. 228, 58–64 (1996).
  CAS PubMed Google Scholar
• Holt, S. E., Wright, W. E. & Shay, J. W. Regulation of telomerase activity in immortal cell lines. Mol. Cell Biol. 16, 2932–2939 (1996).
  CAS PubMed PubMed Central Google Scholar
• Sharma, H. W. et al. Differentiation of immortal cells inhibits telomerase activity. Proc. Natl Acad. Sci. USA 92, 12343–12346 (1995).
  CAS PubMed PubMed Central Google Scholar
• Schneider, E. L. & Mitsui, Y. The relationship between in vitro cellular aging and in vivo human age. Proc. Natl Acad. Sci. USA 73, 3584–3588 (1976).
  CAS PubMed PubMed Central Google Scholar
• Allsopp, R. C. et al. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl Acad. Sci. USA 89, 10114–10118 (1992).
  CAS PubMed PubMed Central Google Scholar
• Cristofalo, V. J., Allen, R. G., Pignolo, R. J., Martin, B. G. & Beck, J. C. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc. Natl Acad. Sci. USA 95, 10614–10619 (1998).
  CAS PubMed PubMed Central Google Scholar
• Kipling, D. & Faragher, R. G. Telomeres: ageing hard or hardly ageing? Nature 398, 191, 193 (1999).
  CAS PubMed Google Scholar
• Klapper, W., Parwaresch, R. & Krupp, G. Telomere biology in human aging and aging syndromes. Mech. Ageing Dev. 122, 695–712 (2001).
  CAS PubMed Google Scholar
• Marciniak, R. A. & Johnson, F. B. & Guarente, L. Dyskeratosis congenita, telomeres and human ageing. Trends Genet. 16, 193–195 (2000).
  CAS PubMed Google Scholar
• Mitchell, J. R., Wood, E. & Collins, K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402, 551–555 (1999).
  CAS PubMed Google Scholar
• Vulliamy, T. et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413, 432–435 (2001).
  CAS PubMed Google Scholar
• Ito, H. et al. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. Clin. Cancer Res. 4, 2807–2810 (1998).
  CAS PubMed Google Scholar
• Takakura, M., Kyo, S., Kanaya, T., Tanaka, M. & Inoue, M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 58, 1558–1561 (1998).
  CAS PubMed Google Scholar
• Shammas, M. A., Simmons, C. G., Corey, D. R. & Shmookler Reis, R. J. Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells. Oncogene 18, 6191–6200 (1999).
  CAS PubMed Google Scholar
• Hayakawa, N. et al. Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro. Biochemistry 38, 11501–11507 (1999).
  CAS PubMed Google Scholar
• Hamilton, S. E., Simmons, C. G., Kathiriya, I. S. & Corey, D. R. Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chem. Biol. 6, 343–351 (1999).
  CAS PubMed Google Scholar
• Minev, B. et al. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proc. Natl Acad. Sci. USA 97, 4796–4801 (2000).
  CAS PubMed PubMed Central Google Scholar